Abbott is recalling their HeartMate Touch System (version 1.0.32) for risk of unexpected pump stop or start. There are 1,560 devices recalled in the U.S. and this recall is “a correction, not a product removal,” the FDA noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ABT:
- Abbott announces new data from studies with GLP-1 medicines and Freestyle Libre
- Abbott Declares 401st Consecutive Quarterly Dividend
- Abbott announces FDA voted in favor of its TriClip System
- ABT, PEP: 2 Dividend Aristocrat Stocks Hedge Funds are Bullish On
- Insulet gets CE Mark approval of Omnipod 5 integration with FreeStyle Libre 2